ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,083Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 910

$417K Total Retail Price of All Prescriptions

Rank: 252 out of 910

613 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,757 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 519 499 1 1
SIMVASTATIN 366 357 2 3
LOSARTAN POTASSIUM 350 336 3 15
OMEPRAZOLE 317 300 4 5
METFORMIN HCL 230 220 5 6
TRIAMTERENE-HCTZ 188 181 6 39
METOPROLOL TARTRATE 187 186 7 7
ATENOLOL 185 185 8 10
LISINOPRIL 180 177 9 2
ZOLPIDEM TARTRATE 176 166 10 17
METOPROLOL SUCCINATE 167 167 11 21
AMLODIPINE BESYLATE 160 160 12 4
TRAMADOL HCL 158 152 13 25
HYDROCODONE-ACETAMINOPHEN 148 143 S3 14 8
LOVASTATIN 143 143 15 20
PANTOPRAZOLE SODIUM 138 131 16 27
WARFARIN SODIUM 137 137 17 11
GABAPENTIN 124 123 18 13
SERTRALINE HCL 119 119 19 24
FUROSEMIDE 118 107 20 9
TAMSULOSIN HCL 118 111 20 29
TRAZODONE HCL 114 104 22 37
ALLOPURINOL 91 86 23 33
CIPROFLOXACIN HCL 86 85 24 48
POTASSIUM CHLORIDE 83 82 25 18
DONEPEZIL HCL 77 77 26 32
LOSARTAN-HYDROCHLOROTHIAZIDE 77 70 26 79
AZITHROMYCIN 75 68 28 41
CLOPIDOGREL 73 73 29 35
DOXAZOSIN MESYLATE 71 71 30 62
ALENDRONATE SODIUM 68 66 31 22
CRESTOR 68 68 31 26
FLUTICASONE PROPIONATE 67 55 33 23
HYDROCHLOROTHIAZIDE 66 65 34 12
ALPRAZOLAM 58 55 35 172
LORAZEPAM 57 55 36 151
CARVEDILOL 55 55 37 36
NIFEDIPINE ER 55 47 37 107
JANUVIA 51 51 39 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.